Showing results (71-80 of 86) with videos related to
Sort By:
Pageof 9
Molecular Pharmaceutics|July 3, 2019
Validation of Thiosemicarbazone Compounds as P-Glycoprotein Inhibitors in Human Primary Brain-Blood Barrier and Glioblastoma Stem CellsIris Chiara Salaroglio, Carmen Abate, Barbara Rolando, et al.Journal of Medicinal Chemistry|November 18, 2024
First-In-Class Thiosemicarbazone Metal Complexes Targeting the Sigma-2 Receptor (S2R) as an Innovative Strategy against Pancreatic CancerAlessandra Barbanente, Joanna Kopecka, Daniele Vitone, et al.Journal of Medicinal Chemistry|March 15, 2023
Development of Fluorescent 4-[4-(3H-Spiro[isobenzofuran-1,4'-piperidin]-1'-yl)butyl]indolyl Derivatives as High-Affinity Probes to Enable the Study of σ Receptors via Fluorescence-Based TechniquesFrancesca Serena Abatematteo, Maria Majellaro, Bianca Montsch, et al.Scientific Reports|August 7, 2023
A conformational rearrangement of the SARS-CoV-2 host protein sigma-1 is required for antiviral activity: insights from a combined in-silico/in-vitro approachFrancesca Serena Abatematteo, Pietro Delre, Ivan Mercurio, et al.Eneuro|October 8, 2020
Proceedings from the Fourth International Symposium on σ-2 Receptors: Role in Health and DiseaseNicholas J Izzo, Martí Colom-Cadena, Aladdin A Riad, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 17, 2026
Unveiling the molecular crosstalk between the purinergic P2X7 receptor and cannabinoid subtype 2 receptor in human microglial HMC3 cells: New insights for multitarget therapies in neuroinflammationImane Ghafir El Idrissi, David Moreira Alvarez, Rocío Piña Márquez, et al.European Journal of Medicinal Chemistry|January 20, 2020
Design and synthesis of fluorescent ligands for the detection of cannabinoid type 2 receptor (CB2R)Francesco Spinelli, Roberta Giampietro, Angela Stefanachi, et al.European Journal of Medicinal Chemistry|January 19, 2023
N-adamantyl-anthranil amide derivatives: New selective ligands for the cannabinoid receptor subtype 2 (CB2R)Giovanni Graziano, Pietro Delre, Francesca Carofiglio, et al.Journal of Experimental & Clinical Cancer Research : CR|July 15, 2025
CC48 a new CB2R agonist/FAAH inhibitor dual drug blocks gastric cancer progression and overcomes paclitaxel resistanceAnnalisa Schirizzi, Natasha Renna, Giampiero De Leonardis, et al.Journal of Medicinal Chemistry|December 21, 2022
Development of N-(1-Adamantyl)benzamides as Novel Anti-Inflammatory Multitarget Agents Acting as Dual Modulators of the Cannabinoid CB2 Receptor and Fatty Acid Amide HydrolaseFrancesca Intranuovo, Leonardo Brunetti, Pietro DelRe, et al.Pageof 9